Mineralys Therapeutics, Inc. (MLYS)
25.36
-0.31
(-1.21%)
USD |
NASDAQ |
Sep 01, 09:58
Mineralys Therapeutics Cash from Operations (Annual) : -142.42M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -142.42M |
| December 31, 2024 | -166.31M |
| December 31, 2023 | -81.17M |
| Date | Value |
|---|---|
| December 31, 2022 | -29.22M |
| December 31, 2021 | -14.56M |
| December 31, 2020 | -2.463M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| MapLight Therapeutics, Inc. | -138.14M |
| Evommune, Inc. | -76.44M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |